🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +11.97% on $543A.T in just 96h 1m.
LYT
$LYTIX.OL
🔒 EuropeLYTIX BIOPHARMA ASA
📅 Next Catalyst: Nov 11, 2026 (☀️ Open) 🏛️ EURONEXT OSLO
📁 Health Technology
🏭 Pharmaceuticals Major
AVG HISTORICAL GAP
+0.50%
MAX GAP RECORD
+0.50%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $LYTIX.OL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$LYTIX.OL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 11, 2026 Earnings Release 2026-11-11 (BEFORE OPEN) | 🔮 UPCOMING 🔒 |
| Aug 27, 2026 Earnings Release 2026-08-27 (AFTER CLOSE) |
+0.50%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
0.5%
Bullish Gaps (0)
Bearish Gaps (0)
Neutral / Flat (1)
📖 Intelligence Summary
Lytix Biopharma ASA engages in the development of novel drugs for the treatment of resistant bacterial and fungal infections, as well as oncology treatments. The company was founded by Øystein Rekdal and John Sigurd Mjøen Svendsen in 2003 and is headquartered in Tromso, Norway.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗